These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24373832)

  • 1. Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.
    Conn PM; Smithson DC; Hodder PS; Stewart MD; Behringer RR; Smith E; Ulloa-Aguirre A; Janovick JA
    Pharmacol Res; 2014 May; 83():38-51. PubMed ID: 24373832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs.
    Smithson DC; Janovick JA; Conn PM
    Methods Enzymol; 2013; 521():3-16. PubMed ID: 23351731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay strategies for identification of therapeutic leads that target protein trafficking.
    Conn PM; Spicer TP; Scampavia L; Janovick JA
    Trends Pharmacol Sci; 2015 Aug; 36(8):498-505. PubMed ID: 26067100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screen for pharmacoperones of the vasopressin type 2 receptor.
    Conn PM; Smith E; Hodder P; Janovick JA; Smithson DC
    J Biomol Screen; 2013 Sep; 18(8):930-7. PubMed ID: 23640875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugs.
    Janovick JA; Park BS; Conn PM
    PLoS One; 2011; 6(7):e22784. PubMed ID: 21818389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor antagonism/agonism can be uncoupled from pharmacoperone activity.
    Janovick JA; Spicer TP; Smith E; Bannister TD; Kenakin T; Scampavia L; Conn PM
    Mol Cell Endocrinol; 2016 Oct; 434():176-85. PubMed ID: 27389877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Pharmacoperones Capable of Rescuing the Functionality of Misfolded Vasopressin 2 Receptor Involved in Nephrogenic Diabetes Insipidus.
    Smith E; Janovick JA; Bannister TD; Shumate J; Scampavia L; Conn PM; Spicer TP
    J Biomol Screen; 2016 Sep; 21(8):824-31. PubMed ID: 27280550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.
    Janovick JA; Spicer TP; Bannister TD; Scampavia L; Conn PM
    PLoS One; 2017; 12(8):e0181830. PubMed ID: 28767678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological chaperoning: a primer on mechanism and pharmacology.
    Leidenheimer NJ; Ryder KG
    Pharmacol Res; 2014 May; 83():10-9. PubMed ID: 24530489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding.
    Ulloa-Aguirre A; Zariñán T; Conn PM
    Rev Invest Clin; 2015; 67(1):15-9. PubMed ID: 25857579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor.
    Conn PM; Smith E; Spicer T; Chase P; Scampavia L; Janovick JA
    Assay Drug Dev Technol; 2014 May; 12(4):238-46. PubMed ID: 24831790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening.
    Madoux F; Janovick JA; Smithson D; Fargue S; Danpure CJ; Scampavia L; Chen YT; Spicer TP; Conn PM
    Assay Drug Dev Technol; 2015; 13(1):16-24. PubMed ID: 25710543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
    Janovick JA; Brothers SP; Cornea A; Bush E; Goulet MT; Ashton WT; Sauer DR; Haviv F; Greer J; Conn PM
    Mol Cell Endocrinol; 2007 Jun; 272(1-2):77-85. PubMed ID: 17555869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15 years of zebrafish chemical screening.
    Rennekamp AJ; Peterson RT
    Curr Opin Chem Biol; 2015 Feb; 24():58-70. PubMed ID: 25461724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy.
    Janovick JA; Stewart MD; Jacob D; Martin LD; Deng JM; Stewart CA; Wang Y; Cornea A; Chavali L; Lopez S; Mitalipov S; Kang E; Lee HS; Manna PR; Stocco DM; Behringer RR; Conn PM
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21030-5. PubMed ID: 24324164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
    Hou ZS; Ulloa-Aguirre A; Tao YX
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development.
    Drosopoulos K; Linardopoulos S
    Methods Mol Biol; 2019; 1953():33-42. PubMed ID: 30912014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.
    Ulloa-Aguirre A; Conn PM
    Curr Drug Targets; 2016; 17(13):1471-81. PubMed ID: 26953247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator].
    Prudent R; Soleilhac E; Barette C; Fauvarque MO; Lafanechère L
    Med Sci (Paris); 2013 Oct; 29(10):897-905. PubMed ID: 24148129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity.
    Smith E; Janovick JA; Bannister TD; Shumate J; Ganapathy V; Scampavia L; Spicer TP
    Sci Rep; 2020 Jun; 10(1):10579. PubMed ID: 32601341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.